{"id":33677,"date":"2025-05-01T06:48:45","date_gmt":"2025-05-01T06:48:45","guid":{"rendered":"https:\/\/g-medtech.com\/news\/?p=33677"},"modified":"2025-05-01T06:52:05","modified_gmt":"2025-05-01T06:52:05","slug":"deepull-raises-e50-million-series-c-for-rapid-sepsis-diagnostic-system","status":"publish","type":"post","link":"https:\/\/g-medtech.com\/news\/deepull-raises-e50-million-series-c-for-rapid-sepsis-diagnostic-system\/","title":{"rendered":"deepull Raises \u20ac50 Million Series C for Rapid Sepsis Diagnostic System"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Barcelona-based <a href=\"https:\/\/g-medtech.com\/database\/medtech-players\/index\/deepull\/\" target=\"_blank\" rel=\"noreferrer noopener\">deepull<\/a> has closed an oversubscribed \u20ac50 million Series C round co-led by Columbus Venture Partners, Panak\u00e8s Partners, and M\u00e9rieux Equity Partners to advance its UllCORE sepsis diagnostic system. The FDA Breakthrough Designated technology identifies 95% of sepsis-causing pathogens and antibiotic resistance genes directly from blood in one hour, compared to the days required by current culture methods. The funds will accelerate clinical validation and regulatory approvals for the fully automated system, which could transform the diagnosis of sepsis, which currently contributes to 1 in 3 hospital deaths in the U.S. and 30-40% mortality worldwide.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;The strong support from investors validates our potential to redefine sepsis diagnostics,&#8221; said Jordi Carrera, CEO of deepull. The UllCORE system addresses critical limitations of current methods, which often miss pathogens due to non-specific symptoms and long turnaround times. Its multiplex PCR technology detects microbial DNA directly from whole blood, providing actionable results during the critical early window when treatment is most effective.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Investors highlighted deepull&#8217;s transformative potential, with Panak\u00e8s Partners citing its extensive search for optimal sepsis solutions and M\u00e9rieux Equity Partners recognizing the early promise of the technology. &#8220;This positions us to deliver a paradigm-shifting diagnostic to global healthcare systems,&#8221; added Rick Ivey, Chairman of deepull. The financing marks a critical step in the commercialization of a solution that could significantly improve outcomes for sepsis patients worldwide.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Barcelona biotech deepull secures \u20ac50 million to advance its FDA Breakthrough-designated UllCORE system, a one-hour blood test that detects 95% of sepsis-causing pathogens and aims to replace days-long culture methods.<\/p>\n","protected":false},"author":2,"featured_media":33678,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[488,6,675,10],"tags":[594,788,792],"class_list":["post-33677","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","category-europe","category-ivds","category-strategic-development","tag-financing","tag-sepsis","tag-spain"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/33677","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/comments?post=33677"}],"version-history":[{"count":3,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/33677\/revisions"}],"predecessor-version":[{"id":33681,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/33677\/revisions\/33681"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media\/33678"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media?parent=33677"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/categories?post=33677"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/tags?post=33677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}